Zylox-Tonbridge Medical Technology Co (HKSE:02190) Capex-to-Revenue : 0.26 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Zylox-Tonbridge Medical Technology Co's Capital Expenditure for the six months ended in Dec. 2023 was HK$-83.59 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$325.53 Mil.

Hence, Zylox-Tonbridge Medical Technology Co's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.26.

Zylox-Tonbridge Medical Technology Co Capex-to-Revenue Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zylox-Tonbridge Medical Technology Co Capex-to-Revenue Chart

Zylox-Tonbridge Medical Technology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Capex-to-Revenue

8.46

1.63

0.50

0.44

0.36

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capex-to-Revenue	Get a 7-Day Free Trial				0.53	0.45	0.42	0.50	0.26

Competitive Comparison of Zylox-Tonbridge Medical Technology Co's Capex-to-Revenue

For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zylox-Tonbridge Medical Technology Co's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's Capex-to-Revenue falls into.

Zylox-Tonbridge Medical Technology Co Capex-to-Revenue Calculation

Zylox-Tonbridge Medical Technology Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-208.823)	/	577.246
	=	0.36

Zylox-Tonbridge Medical Technology Co's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-83.589)	/	325.534
	=	0.26

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Zylox-Tonbridge Medical Technology Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 Keji Avenue, Yuhang Street, 1st & 2nd Floors, Building 1, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.zyloxtb.com

Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries.

Executives

Gan Zhou Ti Tan Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2501 Other
Su Zhou Tai Hong Jing Hui Tou Zi Zhong Xin You Xian He Huo	2501 Other
Five Investment Limited	2501 Other
Highlight Medical Limited	2501 Other
Ourea Biotech Hk Limited	2501 Other
Wang Stephen Hui	2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Tie Si Yi Gu Quan Tou Zi He Huo Qi Ye You Xian He Huo	2501 Other
Jia Jian Tou Zi You Xian Gong Si	2501 Other
Wea Enterprises ,llc	2401 A concert party to an agreement to buy shares
Hu Zhou Yu Yi Hui Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Ning Bo Gui Qiao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Zhu Hai Gui Chuang Gu Quan Tou Zi Zhong Xin You Xian He Huo	2401 A concert party to an agreement to buy shares
Hang Zhou Fu Jiang Tou Zi He Huo Qi Ye You Xian He Huo	2401 A concert party to an agreement to buy shares
Zhu Hai Tong Qiao Tou Zi Zhong Xin You Xian He Huo	2401 A concert party to an agreement to buy shares
Li Zheng	2501 Other

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Headlines

No Headlines